Nanalyze |
Intarcia Therapeutics Revolutionizes Diabetes Treatment
Nanalyze Intarcia develops therapies for diseases that require long-term chronic treatment such as Type 2 diabetes. The Intarcia DUROS drug delivery platform stabilizes and delivers therapeutic proteins and peptides. Their lead drug candidate, ITCA 650, is a … |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.